Measuring the costs, benefits, and risks to listed firms as a result of COVID-19 and other epidemic diseases.
The Wheeler Institute supports Professor Tahoun’s new research: Measuring the costs, benefits, and risks to listed firms as a result of COVID-19 and other epidemic diseases.